OnKure Therapeutics Files Definitive Proxy Statement
Ticker: OKUR · Form: DEF 14A · Filed: Apr 16, 2025 · CIK: 1637715
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, corporate-governance
TL;DR
OnKure (ONKR) filed its proxy statement, standard shareholder info, no major news yet.
AI Summary
OnKure Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 16, 2025, for the fiscal year ending December 31, 2025. The company, formerly known as Reneo Pharmaceuticals, Inc. until March 25, 2015, is headquartered in Boulder, Colorado. This filing is a routine disclosure related to shareholder matters and does not contain specific financial results or proposals at this stage.
Why It Matters
This filing is a standard regulatory requirement for public companies, providing shareholders with information regarding upcoming meetings and corporate governance matters.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which typically contains procedural and governance information rather than material financial or strategic news.
Key Players & Entities
- OnKure Therapeutics, Inc. (company) — Registrant
- Reneo Pharmaceuticals, Inc. (company) — Former company name
- 20250416 (date) — Filing date
- 20250527 (date) — Period of report
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxy votes from shareholders for an upcoming shareholder meeting. It contains information about the matters to be voted on, such as director elections, executive compensation, and other corporate proposals.
When was OnKure Therapeutics, Inc. formerly known as Reneo Pharmaceuticals, Inc.?
OnKure Therapeutics, Inc. was formerly known as Reneo Pharmaceuticals, Inc. until March 25, 2015.
What is the filing date of this DEF 14A statement?
The filing date of this DEF 14A statement is April 16, 2025.
Where is OnKure Therapeutics, Inc. headquartered?
OnKure Therapeutics, Inc. is headquartered at 6707 Winchester Circle, Suite 400, Boulder, CO 80301.
What is the fiscal year end for OnKure Therapeutics, Inc.?
The fiscal year end for OnKure Therapeutics, Inc. is December 31.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 16, 2025 regarding OnKure Therapeutics, Inc. (OKUR).